Blog

Advancements in Medical Treatments, Neuroscience, and the Power of Metals – The Babak Lab

Photo from The Babak Lab/LinkedIn

Sep 1, 2024, 16:37

Advancements in Medical Treatments, Neuroscience, and the Power of Metals – The Babak Lab

The Babak Lab shared a post on LinkedIn:

”Weekly Digest: Advancements in Medical Treatments, Neuroscience, and the Power of Metals.

This week’s digest covers groundbreaking FDA approvals, cutting-edge neuroscience research, and the vital role of metals in daily life and cancer treatment. Here’s why you should dive in:

FDA Approves Axatilimab-csfr for cGVHD Treatment.
The FDA has approved axatilimab-csfr for chronic graft-versus-host disease (cGVHD) after two failed systemic therapies. With a 75% overall response rate from the AGAVE-201 trial, this drug offers new hope for patients struggling with cGVHD. Read more.

New Insights on Psilocybin’s Impact on the Brain.
Explore the therapeutic potential of psilocybin in mental health treatment, with insights into how it may reshape brain connectivity to alleviate conditions like depression and anxiety. Read more.

The Role of Gold, Silver, and Copper in Daily Life and Cancer Treatment.
During a few following weeks you will discover how these metals are quietly revolutionizing healthcare and tech, influencing everything from your gadgets to life-saving treatments. Read more.

Don’t miss out on these critical updates—hit follow to stay informed and share your thoughts in the comments!”

Maria Babak shared a post by The Babak Lab on LinkedIn, adding:

”This week’s digest from The Babak Lab is packed with insights that could reshape our understanding of medical treatments and innovation. From the latest FDA approval offering new hope for cGVHD patients to groundbreaking research on psilocybin’s impact on the brain, there’s something here for everyone interested in the future of healthcare.

Definitely worth checking out if you’re keen on staying ahead in the healthcare field!”

Source: The Babak Lab/LinkedIn and Maria Babak/LinkedIn

Maria Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.

Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.